WELL Health Reports $25.6 Million In Revenue For Q1, Net Loss

WELL Health Technologies (TSX: WELL) this morning reported its first quarter 2021 financial results, reporting $25.6 million in revenue for the period along with a net loss of $7.1 million, or a loss of $0.04 per share. On an adjusted EBITDA basis, the company generated just $0.5 million in positive EBITDA.

Revenue for the period was reportedly a record on a quarterly basis, with revenues increasing 150% on a year over year basis from Q1 2020’s revenue of $10.2 million, and an improvement from the $17.2 million recognized in the fourth quarter. With a cost of sales of $15.5 million for the quarter, “adjusted” gross margins came in at 39.3%, with unadjusted numbers not yet filed by the company.

Notably, while the company technically hit its guidance of adjusted EBITDA improving for its Canadian operations, which saw the figure rise to $1.1 million from $417,000 in the fourth quarter, the company posted declining adjusted EBITDA on an overall quarter over quarter basis. The fourth quarter saw $765,000 in adjusted EBITDA, while the current quarter saw just $527,000.

In terms of outlook, the company remains persistent that it will achieve an annualized revenue run rate of $300 million, much of which is to come from the recently acquired CRH Medical. The company has also stated it is committed to achieving organic growth, continue with acquisitions, grow EBITDA, increase operating cash flows, and increase the market share of its digital health products.

WELL Health last traded at $7.31 on the TSX.


Information for this briefing was found via Sedar and WELL Health Technologies Corp. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Silver47 Completes Property-Wide Geochemical, Rock Sampling Program At Adams Plateau, Identifies Numerous Targets

Altamira Gold Identifies Presence Of Second Mineralized Porphyry Body At Cajueiro

Related News

WELL Health Sees Subsidiary CRH Medical Obtain US$300 Million Credit Facility

WELL Health Technologies Corp. (TSX: WELL) announced this morning that its recently acquired CRH Medical...

Monday, April 26, 2021, 08:40:48 AM

Well Health: Canaccord Slashes Price Target To $6

On May 11th, WELL Health Technologies Corp. (TSX: WELL) reported its first quarter financial results....

Wednesday, May 25, 2022, 04:11:00 PM

WELL Health Closes $12.6 Million Acquisition Of Ontario Clinic

WELL Health (TSX: WELL) has closed the acquisition of ExecHealth, the first such purchase of...

Monday, May 3, 2021, 07:31:20 AM

WELL Health Announces Share Buyback Program

WELL Health (TSX: WELL) this morning announced that it intends to purchase previously issued shares....

Wednesday, April 28, 2021, 07:19:29 AM

Well Health To Raise $65.0 Million Via Convertible Debt

Well Health Technologies (TSX: WELL) is returning to the trough just days after reporting its...

Tuesday, November 16, 2021, 08:25:55 AM